procainamide hydrochloride

procainamide hydrochloride (PRONESTYL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

PRONESTYL is a marketed brand name for procainamide hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

procainamide hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.